Literature DB >> 30734057

Linc00299/miR-490-3p/AURKA axis regulates cell growth and migration in atherosclerosis.

Yong Liu1, Yaqing Chen1, Lili Tan1, Hongmei Zhao1, Nuan Xiao2.   

Abstract

Long non-coding RNA (lncRNA) plays a crucial role in regulating various cellular processes in atherosclerosis. The present study identified the regulation of Linc00299, via miR-490-3p targeting Aurora kinase A (AURKA), on migration and proliferation of endothelial cells and vascular smooth muscle cells (VSMCs) during atherosclerosis. The expression of RNAs was assessed by real-time PCR. The proliferation, apoptosis and migration were detected using MTT assay, Annexin V/PI staining and Transwell system, respectively. Bindings of Linc00299/miR-490-3p and subsequent miR-490-3p/AURKA were verified by luciferase and biotin pull-down assays. The protein expression of AURKA was detected by Western blotting. Expressions of Linc00299 and miR-490-3p were upregulated and downregulated in atherosclerosis patients, respectively. Both Linc00299 knockdown and miR-490-3p overexpression suppressed cell proliferation, increased apoptosis and inhibited migration of VSMCs and HUVECs. Linc00299 directly bound to miR-490-3p which targeted AURKA. The regulation of Linc00299 on expression of AURKA and proliferation and migration of VSMCs were dependent on miR-490-3p. Atherosclerosis-increased Linc00299 acts as a sponge of miR-490-3p to upregulate AURKA, and as a result increases proliferation and migration in VSMCs and HUVECs. Our study reveals an important effect of Linc00299/miR-490-3p/AURKA axis on regulating cell proliferation and migration in atherosclerosis.

Entities:  

Keywords:  AURKA; Atherosclerosis; Linc00299; Vascular smooth muscle cells; miR-490-3p

Mesh:

Substances:

Year:  2019        PMID: 30734057     DOI: 10.1007/s00380-019-01356-7

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  25 in total

Review 1.  Inflammation, atherosclerosis, and coronary artery disease.

Authors:  Göran K Hansson
Journal:  N Engl J Med       Date:  2005-04-21       Impact factor: 91.245

Review 2.  Mechanisms of endothelial dysfunction, injury, and death.

Authors:  Jordan S Pober; Wang Min; John R Bradley
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

Review 3.  Long noncoding RNAs in cardiovascular diseases.

Authors:  Shizuka Uchida; Stefanie Dimmeler
Journal:  Circ Res       Date:  2015-02-13       Impact factor: 17.367

4.  High mobility group box-1 induces migration of vascular smooth muscle cells via TLR4-dependent PI3K/Akt pathway activation.

Authors:  Jian Yang; Lihua Chen; Jun Yang; Jiawang Ding; Han Rong; Wusong Dong; Xinxin Li
Journal:  Mol Biol Rep       Date:  2011-06-23       Impact factor: 2.316

5.  The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489.

Authors:  Kun Wang; Fang Liu; Lu-Yu Zhou; Bo Long; Shu-Min Yuan; Yin Wang; Cui-Yun Liu; Teng Sun; Xiao-Jie Zhang; Pei-Feng Li
Journal:  Circ Res       Date:  2014-02-20       Impact factor: 17.367

Review 6.  Monocyte-endothelial cell interactions in the development of atherosclerosis.

Authors:  Javier Mestas; Klaus Ley
Journal:  Trends Cardiovasc Med       Date:  2008-08       Impact factor: 6.677

7.  Disruption of a large intergenic noncoding RNA in subjects with neurodevelopmental disabilities.

Authors:  Michael E Talkowski; Gilles Maussion; Liam Crapper; Jill A Rosenfeld; Ian Blumenthal; Carrie Hanscom; Colby Chiang; Amelia Lindgren; Shahrin Pereira; Douglas Ruderfer; Alpha B Diallo; Juan Pablo Lopez; Gustavo Turecki; Elizabeth S Chen; Carolina Gigek; David J Harris; Va Lip; Yu An; Marta Biagioli; Marcy E Macdonald; Michael Lin; Stephen J Haggarty; Pamela Sklar; Shaun Purcell; Manolis Kellis; Stuart Schwartz; Lisa G Shaffer; Marvin R Natowicz; Yiping Shen; Cynthia C Morton; James F Gusella; Carl Ernst
Journal:  Am J Hum Genet       Date:  2012-12-07       Impact factor: 11.025

8.  A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA.

Authors:  Marcella Cesana; Davide Cacchiarelli; Ivano Legnini; Tiziana Santini; Olga Sthandier; Mauro Chinappi; Anna Tramontano; Irene Bozzoni
Journal:  Cell       Date:  2011-10-14       Impact factor: 41.582

Review 9.  Recent insights into the cellular biology of atherosclerosis.

Authors:  Ira Tabas; Guillermo García-Cardeña; Gary K Owens
Journal:  J Cell Biol       Date:  2015-04-13       Impact factor: 10.539

10.  Sequencing of a patient with balanced chromosome abnormalities and neurodevelopmental disease identifies disruption of multiple high risk loci by structural variation.

Authors:  Jonathon Blake; Andrew Riddell; Susanne Theiss; Alexis Perez Gonzalez; Bettina Haase; Anna Jauch; Johannes W G Janssen; David Ibberson; Dinko Pavlinic; Ute Moog; Vladimir Benes; Heiko Runz
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

View more
  8 in total

1.  A Balanced Reciprocal Translocation t(2;9)(p25;q13) Disrupting the LINC00299 Gene in a Patient with Intellectual Disability.

Authors:  Halinna Dornelles-Wawruk; Romina Soledad Heredia; Milton R de Paula-Junior; Maria Terezinha O Cardoso; Raphael S Bonadio; Bianca F Dos Reis; Aline Pic-Taylor; Silviene F de Oliveira; Juliana F Mazzeu
Journal:  Mol Syndromol       Date:  2019-06-12

2.  Identifying the key microRNAs implicated in atrial fibrillation.

Authors:  Yuejuan Cao; Li Cui
Journal:  Anatol J Cardiol       Date:  2021-06       Impact factor: 1.596

Review 3.  Unveiling ncRNA regulatory axes in atherosclerosis progression.

Authors:  Estanislao Navarro; Adrian Mallén; Josep M Cruzado; Joan Torras; Miguel Hueso
Journal:  Clin Transl Med       Date:  2020-02-03

4.  Constructing a ceRNA-immunoregulatory network associated with the development and prognosis of human atherosclerosis through weighted gene co-expression network analysis.

Authors:  Yaozhong Liu; Na Liu; Qiming Liu
Journal:  Aging (Albany NY)       Date:  2021-01-17       Impact factor: 5.682

5.  Construction and Analysis of the lncRNA-miRNA-mRNA Network Based on Competing Endogenous RNA in Atrial Fibrillation.

Authors:  Xiangyu Ke; Junguo Zhang; Xin Huang; Shuai Li; Meifang Leng; Zebing Ye; Guowei Li
Journal:  Front Cardiovasc Med       Date:  2022-01-24

6.  MicroRNA-363-3p, negatively regulated by long non-coding RNA small nucleolar RNA host gene 5, inhibits tumor progression by targeting Aurora kinase A in colorectal cancer.

Authors:  Qiuyun Guo; Lujia Dong; Chenxiao Zhang; Dechun Liu; Ping Peng
Journal:  Bioengineered       Date:  2022-03       Impact factor: 6.832

7.  Comprehensive analysis of immune-related biomarkers and pathways in intracerebral hemorrhage using weighted gene co-expression network analysis and competing endogenous ribonucleic acid.

Authors:  Yuehan Hao; Xiaoxue Xu; Yuye Wang; Feng Jin; Ling Tang; Wenxu Zheng; Heyu Zhang; Zhiyi He
Journal:  Front Mol Neurosci       Date:  2022-09-26       Impact factor: 6.261

8.  microRNA-204-5p Participates in Atherosclerosis Via Targeting MMP-9.

Authors:  Na Wang; Yuliang Yuan; Shipeng Sun; Guijian Liu
Journal:  Open Med (Wars)       Date:  2020-03-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.